Open AccessAbstract IA25: Targeted therapies for hepatocellular carcinoma
Author(s) -
Bruno Sangro
Publication year - 2017
Publication title -
cancer research
Language(s) - Uncategorized
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.newfront17-ia25
Subject(s) - sorafenib , medicine , erlotinib , everolimus , hepatocellular carcinoma , oncology , targeted therapy , pi3k/akt/mtor pathway , angiogenesis , clinical trial , cancer , cancer research , combination therapy , lenvatinib , signal transduction , epidermal growth factor receptor , biochemistry , chemistry